Bio-path Holdings, INC S-1 registration statements

Bio-Path Holdings is seeking to raise capital through a public offering of common stock and warrants, aiming to fund working capital and general corporate purposes.

Bio-Path Holdings is seeking to raise capital through a public offering of common stock and warrants, while continuing to advance its clinical-stage oncology and obesity-focused drug candidates.

Bio-Path Holdings is registering the resale of up to 483,750 shares of its common stock, issuable upon the exercise of warrants previously issued in private placements.

Bio-Path Holdings files an amendment to its Form S-1 registration statement primarily to include an exhibit related to legal opinion on the securities being registered.

Bio-Path Holdings, Inc. plans to offer up to 1,152,073 shares of common stock, pre-funded warrants, and common warrants to purchase up to 2,304,146 shares of common stock.

Bio-Path Holdings aims to raise capital through a public offering of common stock, pre-funded warrants, and common warrants.